SPIDERIMPLANT patents have been concretely materialized in certified industrial production and/or in custom-made devices. Each product has been tested in the laboratory and validated from a biomechanical point of view. The clinical studies have been developed through clinical applications in various types of atrophy over a period of seven years, and they have been eventually published both in the form of case reports and retrospective studies. At the same time, the results on the use of SpiderImplant products have been presented at various National and International conferences.
| ⇒ | Coccia E., Zanna M., Mascitti M., Santarelli A., Lo Muzio L., Procaccini M. Spiderimplant: an innovative implantological approach to the treatment of atrophic maxilla. 5th National and 1st International SIPMO Symposium. Ancona, 19-20 October 2018. |  |
| ⇒ | Zanna M., Mascitti M., Coccia E., Lo Muzio L., Santarelli A. Spider Zygoma: a new implant rehabilitation technique for atrophic maxilla. J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6):1605-1608. | |
| ⇒ | E. Coccia, M. Mascitti, A. Santarelli, L. Aquilanti, G. Rappelli, M. Procaccini, L. Lo Muzio, M. Zanna. Spiderimplant for treatment of atrophic maxilla: a retrospective clinical study after 5 years. Journal of Osseointegration Periodontics and Prosthodontics June 2019; 11(2):236. | |
| ⇒ | Case Report N°1: MiniZygo - Left vertical maxillary atrophy (24-27) |  | |
| ⇒ | Case Report N°2: SinusImplant - Right vertical maxilary atrophy (14-17) |  | |
| ⇒ | Case Report N°3: PlateImplant - Transverse atrophy of the upper jaw |  | |
| ⇒ | Case Report N°4: PlateImplant - Left vertical and transverse maxillary atrophy (24-27) |  | |
| ⇒ | Case Report N°5: Spider3D - Left vertical maxillary atrophy (23-26) |  | |
| ⇒ | Case Report N°6: SpiderZygoma - Vertical atrophy and edentulism of the upper jaw |  | |
| ⇒ | Case Report N°7: PlateImplant - Transverse atrophy in site 22 |  | |
| ⇒ | Case Report N°8: PlateImplant - Left vertical maxillary atrophy (24-27) |  | |
| ⇒ | Case Report N°9: MiniZygo - Right vertical maxillary atrophy (15-16) |  | |
FAQs
1. Can SinusImplant and MiniZygo implants be used under local anaesthesia?
Yes, since they only involve the maxillary bone.
2. Is the Great Maxillary Sinus Augmentation a safe and risk-free technique?
Sinus Lift is a relatively safe technique but not completely risk-free. There are reported cases of severe complications such as purulent sinusitis and oro-anthral fistulas, for the treatment of which the use of general anaesthesia is often required.
3. Are chronic dehiscence and mucositis rare complications in extra-maxillary zygomatic implantology?
No, they occur with a certain frequency.
4. Can zygomatic implantology procedures be performed under local anaesthesia?
The use of “traditional” zygomatic implants is absolutely not recommended under local anaesthesia.
5. Does the use of general anaesthesia for the insertion of a zygomatic implant affect the cost of surgical treatment?
Yes, enormously, up to ten times the cost of the system itself.
6. In addition to the implant, how much do biomaterials and membranes affect the costs (to the professional) of a Sinus Lift intervention?
Significantly, up to four times the cost of the system itself.
7. Do SinusImplant and MiniZygo always allow immediate loading?
Practically always, with the exception of few very rare cases.
8. In patients with vertical atrophy, what anatomical features make MiniZygo more suitable than Sinus Implant?
A side wall of the papyraceous maxillary sinus.
9. In severe atrophies, does the Great Sinus Lift always allow the simultaneous insertion of implants and immediate loading?
No, practically never. The immediate load can normally be applied about 8-12 months after the Sinus Lift procedure.
10. Is the zygomatic bone part of the jawbone?
No, and this is one of the areas of competence of Maxillofacial Surgeons
11. What professionals are the SinusImplant and MiniZygo solutions most relevant for?
Both Maxillo-Facial Surgeons and Dentists
12. What complications of implantological surgical procedures are most commonly cause of legal disputes?
Iatrogenic sinusitis (from Sinus Lift complications) and inferior alveolar nerve (IAN) injury.
13.Are there any reported cases of the displacement of zygomatic implants into the cranial fossa and/or orbital cavity?
Yes, both cases are reported in literature.
14. Are the zygomatic, infratemporal orbital bones relevant structures for dental procedures?
No, these anatomical structures are only relevant to Maxillo-Facial Surgeons.
15. Does the customization of SPIDERIMPLANT solutions in the pre- and intra-operative phases require specific instrumentation?
No, only standard carving tools are needed.
16. What feature of SPIDERIMPLANT allows for its remarkably low invasiveness?
The firm coupling of several implantological components into a single customised structure.
17. How common are episodes of membrane exposure and bone sequestration after G.B.R. procedures and solid grafts respectively?
Relatively common.
18. Does the absence of a primary implant in the PlateImplant reduce primary stability?
No, thanks to the “locking” effect of the secondary systems.
19. In cases of very strong transverse atrophy, is the application of a PlateImplant an invasive surgical procedure?
Absolutely not, it is the most conservative surgical approach available.
Our brochures
Presentation
brochure
(v.2022)
Brochure
for companies
(v.2022)
Brochure for
med. Professionals
(v.2022)
Brochure
for patients
(v.2022)
Presentations at medical conferences
